Thomas Trimarchi

Thomas Trimarchi is currently the Director at debra. Prior to this, they were with debra of America and before that, BridgeBio. Thomas has also worked with Regeneron Pharmaceuticals, Inc. from January 2017 to December 2018 as Strategy - Immunology and Inflammation and with Goldman Sachs from January 2015 to December 2017 as Biotechnology Equity Research.

Thomas Trimarchi received their PhD in Molecular Oncology and Immunology, Cell and Molecular Biology from New York Medicine Jobs. Thomas also holds a Bachelor of Science in Biology, General from the University of Vermont.